Pluto Biosciences, a Denver, Colorado-based biotech software startup and developer of the Pluto collaborative life sciences platform, raised $1 million in a seed round led by private investors.
Funding will be used to expand the bioinformatics and machine learning-based analyses in its collaborative life sciences platform, democratize access to published research data, and close the gaps in scientific collaboration to drive new, high-impact discoveries.
Company: Pluto Biosciences, Inc.
Round: Seed Round
Funding Month: October 2021
Lead Investors: Private investors
Company Website: https://pluto.bio/
Software Category: Collaborative life sciences platform
About the Company: Pluto is a B2B SaaS platform that empowers researchers to explore their data and make high-quality, meaningful discoveries in a fraction of the time. Researchers can upload data and run statistics- and machine learning-based analyses easily in their browser, with no coding required. The Pluto platform also allows researchers to compare their results against a database of thousands of published experiments, bringing the global scientific community closer so that more life-changing discoveries can reach the world. Pluto Biosciences developed the Pluto platform to empower life sciences organizations to accelerate their research with their own comprehensive, cloud-based lab space. Its secure, collaborative, biological data management and analysis features make bioinformatics more accessible and enable teams to make scientific discoveries faster than ever before.